We are live on
!
Find out more
BPC
Banque Pictet & Cie Portfolio holdings
AUM
$16B
1-Year Est. Return
29.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.07%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$4B
AUM Growth
+$341M
(+9.3%)
Cap. Flow
+$115M
Cap. Flow
% of AUM
2.87%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
502
New
78
Increased
165
Reduced
119
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$33.7M |
| 2 |
American Express
AXP
|
+$22.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$19.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$17.3M |
| 5 |
Abbott
ABT
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$115M |
| 2 |
General Motors
GM
|
+$25.2M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$24M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.4M |
| 5 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.63% |
| 2 | Consumer Discretionary | 11.72% |
| 3 | Consumer Staples | 10.11% |
| 4 | Technology | 9.51% |
| 5 | Energy | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETM
151
DELISTED
PETSMART INC
PETM
| $3.43M | 0.09% |
+57,320
| New | +$3.62M |
|
152
iShares Core S&P 500 ETF
IVV
$902B
| $3.37M | 0.08% |
17,097
-8,113
| -32% | -$1.55M |
|
|
RSX
153
DELISTED
VanEck Russia ETF
RSX
| $3.35M | 0.08% |
127,384
+74,384
| +140% | +$1.83M |
|
154
Vanguard Dividend Appreciation ETF
VIG
$114B
| $3.34M | 0.08% |
42,800
| – | – |
|
155
SPDR Gold Trust
GLD
$141B
| $3.31M | 0.08% |
25,820
| – | – |
|
156
Coca-Cola
KO
$375B
| $3.29M | 0.08% |
77,680
-57,819
| -43% | -$2.35M |
|
157
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.36B
| $3.08M | 0.08% |
+76,650
| New | +$3.04M |
|
158
iShares Core US Aggregate Bond ETF
AGG
$138B
| $3.06M | 0.08% |
+27,965
| New | +$3.04M |
|
159
3D Systems Corp
DDD
$613M
| $3.04M | 0.08% |
50,816
+11,660
| +30% | +$599K |
|
160
APA Corp
APA
$13.2B
| $2.95M | 0.07% |
29,284
-8,311
| -22% | -$753K |
|
|
CTRX
161
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $2.89M | 0.07% |
+65,335
| New | +$2.76M |
|
162
iShares MSCI Spain ETF
EWP
$2.17B
| $2.86M | 0.07% |
+66,825
| New | +$2.82M |
|
|
CAF
163
Morgan Stanley China A Share Fund
CAF
$327M
| $2.85M | 0.07% |
130,000
| – | – |
|
164
VanEck Gold Miners ETF
GDX
$27.4B
| $2.79M | 0.07% |
105,350
+8,500
| +9% | +$204K |
|
165
iShares US Transportation ETF
IYT
$2.29B
| $2.75M | 0.07% |
74,800
+8,000
| +12% | +$282K |
|
166
PUT
Johnson & Johnson
JNJ
$625B
| $2.72M | 0.07% |
26,000
-13,000
| -33% | -$1.31M |
|
167
Ecolab
ECL
$79.9B
| $2.7M | 0.07% |
+24,250
| New | +$2.6M |
|
168
State Street SPDR S&P Homebuilders ETF
XHB
$1.56B
| $2.7M | 0.07% |
82,450
+12,000
| +17% | +$380K |
|
169
Cencora
COR
$61.2B
| $2.54M | 0.06% |
34,980
-2,390
| -6% | -$164K |
|
170
PUT
Procter & Gamble
PG
$339B
| $2.52M | 0.06% |
32,000
-16,000
| -33% | -$1.29M |
|
171
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
| $2.51M | 0.06% |
14,945
-1,350
| -8% | -$224K |
|
172
PUT
Nike
NKE
$61.9B
| $2.48M | 0.06% |
64,000
-32,000
| -33% | -$1.19M |
|
|
SGEN
173
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.48M | 0.06% |
64,740
-4,260
| -6% | -$161K |
|
174
CALL
Apple
AAPL
$4.57T
| $2.47M | 0.06% |
+106,400
| New | +$2.26M |
|
175
ConocoPhillips
COP
$141B
| $2.46M | 0.06% |
28,669
-1,122
| -4% | -$87.4K |
|
Similar funds
MG
CCMG
CLGM
LCOV
LCIP
UCFA
EF
IG
Banque Pictet & Cie's Q2 2014 Portfolio in Review
As of Q2 2014, Banque Pictet & Cie held 502 positions worth $4B, up 9.3% from $3.66B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Banque Pictet & Cie's Q2 2014 filing shows 78 new, 165 increased, 119 reduced and 42 closed positions. Its largest new stake was Thermo Fisher Scientific: 147,040 shares worth $17.4M. The largest sale was Allergan Inc, an estimated $115M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Banque Pictet & Cie's largest Q2 2014 buy was Thermo Fisher Scientific: 147,040 shares worth $17.4M.
- Banque Pictet & Cie added most to Starbucks in Q2 2014, an estimated $33.7M increase.
- Banque Pictet & Cie's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $115M.
- Banque Pictet & Cie fully exited iShares S&P Mid-Cap 400 Growth ETF in Q2 2014, selling an estimated $10.4M.
- Banque Pictet & Cie's ten largest holdings make up 33% of its $4B portfolio in Q2 2014.
- Banque Pictet & Cie opened 78 new positions and closed 42 in Q2 2014.
- Banque Pictet & Cie's portfolio value rose 9.3% quarter-over-quarter to $4B.
Based on Banque Pictet & Cie's 13F filing for Q2 2014, filed 6 Aug 2014.